MYLAN P157 (Metformin hydrochloride and pioglitazone hydrochloride 850 mg / 15 mg (base))
Pill imprint MYLAN P157 has been identified as Metformin hydrochloride and pioglitazone hydrochloride 850 mg / 15 mg (base).
Metformin/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metformin/pioglitazone 850 mg / 15 mg (base) is not subject to the Controlled Substances Act.
See also related documents.
Images for MYLAN P157 (Metformin hydrochloride and pioglitazone hydrochloride 850 mg / 15 mg (base))
Metformin hydrochloride and pioglitazone hydrochloride
- Imprint:
-
MYLAN
P157 - Strength:
- 850 mg / 15 mg (base)
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
More resources
- Metformin hydrochloride and pioglitazone hydrochloride Side Effects
- Metformin hydrochloride and pioglitazone hydrochloride and Pregnancy
- Metformin hydrochloride and pioglitazone hydrochloride Drug Interactions
- Support Group Q & A
- 6 Reviews for Metformin hydrochloride and pioglitazone hydrochloride - Add your own review/rating
Metformin hydrochloride and pioglitazone hydrochloride is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
